Model X-Ray Image Data into ADaM BDS Structure

Slides:



Advertisements
Similar presentations
CDISC News: ADaM Basel, September 2, 2008.
Advertisements

ADaM Implementation Guide: It’s Almost Here. Are You Ready?
Industry Issues: Dataset Preparation for Time to Event Analysis Davis Gates Schering Plough Research Institute.
Experience and process for collaborating with an outsource company to create the define file. Ganesh Sankaran TAKE Solutions.
Analysis Data Model (ADaM)
UC5:Assigning of Epoch after treatment discontinuation (NS)
CDISC ADaM 2.1 Implementation: A Challenging Next Step in the Process Presented by Tineke Callant
Quick tour of CDISC’s ADaM standard
Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
ADaM Standards Wouter van Wyk. Why ADaM –SDTM purpose is to provide collected data Not designed for ease of analysis –ADaM purpose is to provide data.
Basic guidelines for the creation of a DW Create corporate sponsors and plan thoroughly Determine a scalable architectural framework for the DW Identify.
Creating Architectural Descriptions. Outline Standardizing architectural descriptions: The IEEE has published, “Recommended Practice for Architectural.
Metadata Management – Our Journey Thus Far
It’s about Time! (to Event)
© Tefko Saracevic, Rutgers University1 digital libraries and human information behavior Tefko Saracevic, Ph.D. School of Communication, Information and.
Gregory Steffens Novartis Associate Director, Programming NJ CDISC Users’ Group 17 April 2014 Supplemental Qualifiers.
MGT-555 PERFORMANCE AND CAREER MANAGEMENT
Emerging Technologies Semantic Web and Data Integration This meeting will start at 5 min past the hour As a reminder, please place your phone on mute unless.
23 August 2015Michael Knoessl1 PhUSE 2008 Manchester / Michael Knoessl Implementing CDISC at Boehringer Ingelheim.
Principles and Practicalities in Building ADaM Datasets Cathy Barrows CDISC Users’ Group – May 25, 2012 Previously presented at: PhUSE Single Day Event.
A Taste of ADaM Presented by: Peng/Zik Liu MSD (Shanghai) Pharma Co.
CBER CDISC Test Submission Dieter Boß CSL Behring, Marburg 20-Mar-2012.
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
Implementation of a harmonized, report-friendly SDTM and ADaM Data Flow General by Marie-Rose Peltier Experience by Marie Fournier Groupe Utilisateurs.
Overview and feed-back from CDISC European Interchange 2008 (From April 21 st to 25 th, COPENHAGEN) Groupe des Utilisateurs Francophones de CDISC Bagneux.
© Copyright 2008 ADaM Validation and Integrity Checks Wednesday 12 th October 2011 Louise Cross ICON Clinical Research, Marlow, UK.
How to go from an SDTM Finding Domain to an ADaM-Compliant Basic Data Structure Analysis Dataset: An Example Qian Wang, MSD, Brussels, Belgium Carl Herremans,
2 FOR INTERNAL USE ONLY Project Chartering  Define the components of a project charter  Develop a project idea into an effective project charter  Review.
Alun, living with Parkinson’s disease QS Domain: Challenges and Pitfalls Knut Müller UCB Biosciences Conference 2011 October 9th - 12th, Brighton UK.
1 Unit 1 Information for management. 2 Introduction Decision-making is the primary role of the management function. The manager’s decision will depend.
Module 1: Statistical Issues in Micro simulation Paul Sousa.
Research based, people driven CDISC ADaM Datasets - from SDTM to submission CDISC Experience Exchange and ADaM Workshop 15 Dec 2008 Zoë Williams, LEO Pharma.
Protection of frequency tables – current work at Statistics Sweden Karin Andersson Ingegerd Jansson Karin Kraft Joint UNECE/Eurostat.
1 Efficacy of Acamprosate: Clinical Issues Celia Jaffe Winchell, M.D. Medical Team Leader Addiction Drug Products.
Paper Title Authors names Conference and Year Presented by Your Name Date.
1 Much ADaM about Nothing – a PROC Away in a Day EndriPhUSE Conference Rowland HaleBrighton (UK), 9th - 12th October 2011.
Level 1-2 Trigger Data Base development Current status and overview Myron Campbell, Alexei Varganov, Stephen Miller University of Michigan August 17, 2000.
UC3: Complications Related to Unscheduled performed instead scheduled (TK) Raw visit numberVISITNUMLBDYLBDTC 2missing VISITVISITNUMSVDYSVDTCSVUPDES.
CHAPTER 51 LINKED LISTS. Introduction link list is a linear array collection of data elements called nodes, where the linear order is given by means of.
1. © CDISC 2014 Presented by Angelo Tinazzi, Cytel Inc, Geneva, Switzerland Presented at 2014 CDISC Europe Interchange, Paris Adapted for CDISC UK Network.
Øyvind Langsrud New Challenges for Statistical Software - The Use of R in Official Statistics, Bucharest, Romania, 7-8 April 1 A variance estimation R.
How Good is Your SDTM Data? Perspectives from JumpStart Mary Doi, M.D., M.S. Office of Computational Science Office of Translational Sciences Center for.
Conjoint Analysis. 1. Managers frequently want to know what utility a particular product feature or service feature will have for a consumer. 2. Conjoint.
1 Middle East Users Group 2008 Self-Service Engine & Process Rules Engine Presented by: Ryan Flemming Friday 11th at 9am - 9:45 am.
Principles and Practicalities in Building ADaM Datasets
A Systematic Review of ADaM IG Interpretation
Notes on Logistic Regression
MANAGEMENT OF DASHBOARD MODELS
Rudi Seljak, Aleš Krajnc
Creating ADaM Friendly Analysis Data from SDTM Using Meta-data by Erik Brun & Rico Schiller (CD ) H. Lundbeck A/S 13-Oct
Traceability between SDTM and ADaM converted analysis datasets
It’s about Time! (to Event)
Patterns emerging from chaos
An Active Collection using Intermediate Estimates to Manage Follow-Up of Non-Response and Measurement Errors Jeannine Claveau, Serge Godbout and Claude.
Improving the efficiency of editing in ONS business surveys
A SAS macro to check SDTM domains against controlled terminology
To change this title, go to Notes Master
Fabienne NOEL CDISC – 2013, December 18th
Patients included in linear extrapolation and observed/last observation carried forward analyses at week 48. Patients who were rescued or discontinued.
Visualizing Subject Level Data in Clinical Trial Data
TRAINING OF FOCAL POINTS ON THE CountrySTAT/FENIX SYSTEM
Sub-Regional Workshop on International Merchandise Trade Statistics Compilation and Export and Import Unit Value Indices 21 – 25 November Guam.
An FDA Statistician’s Perspective on Standardized Data Sets
Analysis Data Model (ADaM)
Percentage of patients with RA achieving DAS28(CRP)<2
Joint damage progression evaluated as a comparison between abatacept plus MTX (grey bar) and placebo plus MTX groups (open bar). Joint damage progression.
A handbook on validation methodology. Metrics.
STEPS Site Report.
Patient-level radiographic progression of structural joint damage at year 1 and year 2 by original randomisation. Patient-level radiographic progression.
ADME Study PK SDTM/ADAM And Graph
Presentation transcript:

Model X-Ray Image Data into ADaM BDS Structure Vincent Guo NJ CDISC Users Group meeting, Sep 17, 2014

Introduction X-ray image data is important and special efficacy data To demonstrate long time efficacy on joint/bone structural preservation Score system developed to quantify the assessment Complex This presentation will cover: SDTM data for X-ray image Analysis requirements Challenges, options considered, and solutions as to bridge the gap from source data to analysis Demo of the dataset | Presentation Title | Presenter Name | Date | Subject | Business Use Only

SDTM Data Data is collected in a custom domain. Assessments (X-ray images) are performed by test location (joint) body side visit two different readers and possible a third consensus read. Joint score is the result recorded in the source data. | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Analysis Requirements Evaluation of Joint structural damage by visit Parameter: Modified total Sharp score (mTSS) change from baseline Covariate: Modified total Sharp score (mTSS) baseline Consensus read to be used Evaluation of the proportion of subjects without disease progression at each visit Comparison of proportion of subjects with no disease progression between the two periods: from baseline to W24 versus from W24 to W52. | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Definition and Derivation Modified total Sharp score (mTSS) change from baseline for post-baseline assessments Defined as sum of joint scores change from baseline Imputation needed in case of missing joint score change from baseline: Joints grouped into segments; segment score calculated as subtotal of joint score change from baseline within the segment: Missing imputed with average of change from baseline of non-missing joints if >50% of joints non-missing; otherwise, segment score is missing. Total score (mTSS): sum of segment scores Missing imputed with average of non-missing segments if >50% of segments non- missing; otherwise, total score is missing. | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Definition and Derivation Demo of imputation of missing joint change from baseline | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Definition and Derivation Modified total Sharp score (mTSS) baseline Defined as sum of joint score at baseline No imputation in case of missing joint scores at baseline | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Definition and Derivation No disease progression At each visit, defined as mTSS change from baseline <= 0 Comparison between two periods, defined as change of mTSS change from baseline <= 0 | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Challenge #1: How to create PARAM for mTSS change from baseline? Solution Alternative PARAM created for mTSS change from baseline (PARAMCD=TSSCBSI) AVAL stores change from baseline Only for post-baseline visits Different PARAMs for Reader 1, Reader 2 and consensus read. No creation of PARAM for individual joints or individual segments Because of the definition of mTSS change from baseline, conventional method that calculates absolute total score for each visit and change from baseline at total score level is not applicable | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Challenge #2: Need baseline score to be covariate Solution Alternative PARAM created for mTSS baseline (PARAMCD=TSSBS) AVAL stores baseline Only for baseline visit Different PARAMs for Reader 1, Reader 2 and consensus read. No creation of PARAM for individual joints or individual segments Custom variable BASESCO (baseline mTSS score) created as a column using AVAL of this PARAM Leave it to reporting/analysis level without adding baseline score as a variable in the dataset, which is not analysis ready. Conventional BASE is not applicable for this purpose. | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Demo of ADaM Dataset for Challenge #1 and #2: | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Challenge #3: How to handle various imputations? Challenge Solution Alternative (a) Imputing missing data Linear extrapolation LOCF Apply ADaM methodology (insert new rows and use DTYPE) (b) Imputing missing consensus read by taking the average of Reader 1 and Reader 2 New rows for the imputed consensus reads Custom variable to indicate consensus type: original CONSENSUS (collected) or AVERAGE (imputed) It is not appropriate to use DTYPE as ADaM rule specifies that DTYPE should be used to indicate rows that are derived within a given value of PARAM but this imputation is done between parameters | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Demo of ADaM Dataset for Challenge #3: | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Challenge #4: How to handle no disease progression? Challenge Solution Alternative (a) Evaluation of the proportion of subjects without disease progression at each visit AVAL is change from baseline (PARAMCD=TSSCBSI) CRIT1 (AVAL<=0)  no disease progression at each visit Pros: No need to create new PARAM (new rows) Easily preserve DTYPE information (linear extrapolation, LOCF) for imputation as everything is at the same row. Create new PARAM Cons: Dataset actually becomes more complex due to imputation. | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Demo of ADaM Dataset for Challenge #4a: | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Challenge #4: How to handle disease progression? Challenge Solution Alternative (b) Comparison of proportion of subjects with no disease progression between the two periods: from baseline to W24 versus from W24 to W52. For PARAMCD=TSSCBSI, Populate: BASETYPE (W24 AVAL as baseline) BASE (W24 AVAL) CHG (change of change from baseline  change from W24 to W52 = W52 AVAL – W24 AVAL[BASE]) CRIT2 (BASE<=0)  no disease progression from baseline to W24 CRIT3 (CHG<=0)  no disease progression from W24 to W52 where AVISIT=W52 Pros: Analysis ready “one proc away”. Easily keep DTYPE information for imputation Data flow can be traced within the dataset. Cons: Dataset looks complex at the first sight Create new PARAM (e.g. one for disease progression from baseline visit to W24, another one for disease progression from W24 to W52) Dataset looks simpler Not analysis ready “one proc away”. Data flow is not easily traced within the dataset. | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Challenges and Solutions Demo of ADaM Dataset for Challenge #4b: USUBJID PARAMCD AVISITN AVAL CRIT1FL (AVAL<=0) ABLFL BASE CHG CRIT2FL (BASE<=0) CRIT3FL (CHG<=0) BASETYPE DTYPE CONSTYPE BASESCO 1 TSSBS1 10   TSSCBSI1 16 2 N 3 WEEK 24 AVAL AS BASELINE 24 Y ENDPOINT LOCF 52 -1 -4 TSSBS2 11 TSSCBSI2 4 4.5 6 -4.5 TSSBS CONSENSUS TSSCBSI -0.5 (CHG 0-52) (CHG 0-24) -3.5 (CHG 24-52) AVERAGE | Presentation Title | Presenter Name | Date | Subject | Business Use Only

Conclusion Data is collected in custom domain which contains special elements that are not in standard findings domains such as LB, VS, EG. Complicated definitions and derivations lead to complexity in design and implementation of ADaM dataset. ADaM principles and methodology have been followed and adapted. It has demonstrated that sufficient tools are available for us to create a compliant and “analysis ready” ADaM dataset for this custom domain although some special situations require us to go beyond what’s specified in ADaM IG. The ADaM dataset created allows us to perform analyses easily. | Presentation Title | Presenter Name | Date | Subject | Business Use Only